Basal Cell Carcinoma Follow Up Study. A Prospective Study

Status: Active_not_recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The purpose of this study is to find out more about how Basal Cell Carcimonas/BCCs grow and to learn more effective ways to monitor and treat these common cancers. This study will not provide any type of treatment for the participants' cancer; it is a 3-year observational study to monitor participants' cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients 18 years of age or older

• Diagnosed with at least 1 BCC based on clinical, dermoscopy, RCM and OCT

• Patients with BCCs that have a diameter smaller or equal to 1.5cm, allowing for 0.5cm growth before reaching the cutoff for stage 2 BCC, which would require removal of the BCC.

• Patients with BCCs that have a depth smaller or equal to 0.6mm, to allow for tumor growth of 0.2mm before reaching the depth limitation of OCT imaging (0.8mm)

• Treatment naiive lesions

• Ability to sign informed consent

Locations
United States
New York
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York
Time Frame
Start Date: 2022-07-27
Completion Date: 2026-07
Participants
Target number of participants: 26
Treatments
Participant with Basal Cell Carcinoma/BCC
Participants have been diagnosed with at least 1 Basal Cell Carcinoma/BCC based on clinical, dermoscopy, RCM (reflectance confocal microscopy) and OCT (optical coherence tomography)
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center

This content was sourced from clinicaltrials.gov